Literature DB >> 6787052

Protease digestion of colonic mucin. Evidence for the existence of two immunochemically distinct mucins.

D V Gold, D Shochat, F Miller.   

Abstract

Colonic mucin was prepared by phenol-water partition extraction of th colonic mucosa, followed by ethanol precipitation of the water-soluble material, molecular sieve chromatography, and reductive sodium dodecyl sulfate-disc gel electrophoresis in an agarose-polyacrylamide gradient gel. Although this material as observed to be relatively homogeneous by physical criteria, it was shown to contain at least two components by immunodiffusion. Molecular sieve, ion exchange, adsorption, lectin affinity, and electrophorectic techniques failed to separate the two components. However, by protease digestion employing either 1% w/w pronase or papain, followed by molecular sieve chromatography, we were able to separate at least the portions of the molecules containing the immunodeterminants. Physicochemical and immunologic properties of both components were characteristic of mucins. Mucin A (pronase digest fraction 1 from molecular sieve chromatography) was enriched in threonine, proline, and sialic acid, while mucin B (pronase digest fraction 3 from molecular sieve chromatography) was enriched in serine, alanine, and fucose. Mucin A and mucin b were shown to be immunologically distinct. The evidence suggests that the protease-digested mucin fractions originate from two different mucins, one a sialomucin, the other a fucomucin; however, the alternative explanation, that these two mucin fragments may originate from a single mucin molecule, cannot be ruled out at present.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787052

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Development of anti-human colonic mucin monoclonal antibodies. Characterization of multiple colonic mucin species.

Authors:  D K Podolsky; D A Fournier; K E Lynch
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

2.  Human colonic goblet cells. Demonstration of distinct subpopulations defined by mucin-specific monoclonal antibodies.

Authors:  D K Podolsky; D A Fournier; K E Lynch
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  Fibronectin: source of mannose in a highly purified respiratory mucin.

Authors:  S N Bhattacharyya; B Kaufman; A Khorrami; J I Enriquez; B Manna
Journal:  Inflammation       Date:  1988-10       Impact factor: 4.092

4.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.

Authors:  D K Podolsky; K J Isselbacher
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

5.  Binding of proteolytically-degraded human colonic mucin glycoproteins to the Gal/GalNAc adherence lectin of Entamoeba histolytica.

Authors:  K Chadee; C Ndarathi; K Keller
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

6.  Biochemical characterization of rat colonic mucins secreted in response to Entamoeba histolytica.

Authors:  S K Tse; K Chadee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Colonic mucin synthesis is increased by sodium butyrate.

Authors:  I A Finnie; A D Dwarakanath; B A Taylor; J M Rhodes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

8.  Chemical and histochemical studies of normal and diseased human gastrointestinal tract. I. A comparison between histologically normal colon, colonic tumours, ulcerative colitis and diverticular disease of the colon.

Authors:  P E Reid; C F Culling; W L Dunn; C W Ramey; M G Clay
Journal:  Histochem J       Date:  1984-03

9.  Heterogeneity of rat goblet-cell mucin before and after reduction.

Authors:  R E Fahim; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

10.  Deglycosylation of neutral and acidic human colonic mucin.

Authors:  S N Bhattacharyya; J I Enriquez; B Manna
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.